Stay updated on Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page shows a minor revision update: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedThe study record shows termination and results posted on 2025-12-31, and adds detailed objectives and perioperative treatment plans for pembrolizumab plus vactosertib in colorectal cancer with resectable liver metastases.SummaryDifference4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations now include California; the California Locations subsection and the HHS Vulnerability Disclosure link were removed, and the revision was updated to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision: v3.3.2 was added and revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedA government funding/operating-status notice banner was removed from the page. This change does not affect the study details or eligibility criteria.SummaryDifference0.4%

- Check74 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03844750; the content and layout appear unchanged.SummaryDifference0.5%

Stay in the know with updates to Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.